Predicting tubular reabsorption with a human kidney proximal tubule tissue-on-a-chip and physiologically-based modeling
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Kidney is a major route of xenobiotic excretion, but the accuracy of preclinical data for predicting in vivo clearance is limited by species differences and non-physiologic 2D culture conditions. Microphysiological systems can potentially increase predictive accuracy due to their more realistic 3D environment and incorporation of dynamic flow. We used a renal proximal tubule microphysiological device to predict renal reabsorption of five compounds: creatinine (negative control), perfluorooctanoic acid (positive control), cisplatin, gentamicin, and cadmium. We perfused compound-containing media to determine renal uptake/reabsorption, adjusted for non-specific binding. A physiologically-based parallel tube model was used to model reabsorption kinetics and make predictions of overall in vivo renal clearance. For all compounds tested, the kidney tubule chip combined with physiologically-based modeling reproduces qualitatively and quantitatively in vivo tubular reabsorption and clearance. However, because the in vitro device lacks filtration and tubular secretion components, additional information on protein binding and the importance of secretory transport is needed in order to make accurate predictions. These and other limitations, such as the presence of non-physiological compounds such as antibiotics and bovine serum albumin in media and the need to better characterize degree of expression of important transporters, highlight some of the challenges with using microphysiological devices to predict in vivo pharmacokinetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomonitoring of Perfluoroalkyl Acids in Human Urine and Estimates of Biological Half-Life
Zhang, Y., Beesoon, S., Zhu, L., & Martin, J. W. (2013) · Environmental Science & Technology · doi:10.1021/es401905e · Cited by 530
Microfluidic 3D cell culture: from tools to tissue models
van Duinen, V., Trietsch, S. J., Joore, J., Vulto, P., & Hankemeier, T. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.05.002 · Cited by 500 · cited 1×
“The device preparation and cell seeding protocols were as previously described (Sakolish et al., 2018; Van Ness et al., 2017).”
MethodOrgan/body-on-a-chip based on microfluidic technology for drug discovery
Kimura, H., Sakai, Y., & Fujii, T. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2017.11.003 · Cited by 435 · cited 1×
“Species differences present a major challenge in extrapolating pharmacokinetics from animals to humans (Kimura et al., 2018; Medinsky, 1995), and in vitro testing in 2D culture”
BackgroundMarx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
Harada, K., Inoue, K., Morikawa, A., Yoshinaga, T., Saito, N., & Koizumi, A. (2005) · Environmental Research · doi:10.1016/j.envres.2004.12.003 · Cited by 284
Renal elimination of perfluorocarboxylates (PFCAs)
Han, X., Nabb, D. L., Russell, M. H., Kennedy, G. L., & Rickard, R. W. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200363w · Cited by 250
Yang, C.-H., Glover, K. P., & Han, X. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq219 · Cited by 197 · cited 2×
“For PFOA, the chip data indicated a measurable amount of reabsorption, consistent with what is known about transporter-mediated renal kinetics of PFOA (Worley and Fisher, 2015; Yang et al., 2010).”
MethodResultMathialagan, S., Piotrowski, M. A., Tess, D. A., Feng, B., Litchfield, J., & Varma, M. V. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074294 · Cited by 128
Interaction of perfluorooctanoic acid with human serum albumin
Wu, L.-L., Gao, H.-W., Gao, N.-Y., Chen, F.-F., & Chen, L. (2009) · BMC Structural Biology · doi:10.1186/1472-6807-9-31 · Cited by 81
Scotcher, D., Jones, C., Rostami-Hodjegan, A., & Galetin, A. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.03.018 · Cited by 61
Development of a Dynamic Physiologically Based Mechanistic Kidney Model to Predict Renal Clearance
Huang, W., & Isoherranen, N. (2018) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12321 · Cited by 49 · cited 1×
“The lack of a vascular channel also implies that reabsorption via passive diffusion will not be fully recapitulated by this device, though recent progress has been made in modeling-based prediction of passive reabsorption (Huang and Isoherranen, 2018; Scotcher et al., 2016c) that could be incorporated in the future.”
Background
Cited by
Campbell, S. B., Wu, Q., Yazbeck, J., Liu, C., Okhovatian, S., & Radisic, M. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00640 · Cited by 297
Development of a Dynamic Physiologically Based Mechanistic Kidney Model to Predict Renal Clearance
Huang, W., & Isoherranen, N. (2018) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12321 · Cited by 49
Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium
Rusyn, I., Sakolish, C., Kato, Y., Stephan, C., Vergara, L., Hewitt, P., Bhaskaran, V., Davis, M., Hardwick, R. N., Ferguson, S. S., et al. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac061 · Cited by 43
Self-citationSakolish, C., Tsai, H.-H. D., Lin, H.-C., Bajaj, P., Villenave, R., Ferguson, S. S., Stanko, J. P., Becker, R. A., Hewitt, P., Chiu, W. A., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13030563 · Cited by 11
Self-citation
Metadata
- Authors
- Sakolish, C., Chen, Z., Dalaijamts, C., Mitra, K., Liu, Y., Fulton, T., Wade, T. L., Kelly, E. J., Rusyn, I., & Chiu, W. A.
- Venue
- Toxicology in Vitro
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 63
- Pages
- 104752
- ISSN
- 0887-2333 (ISSN-L)
- OpenAlex
- W2995121336
- Cited by
- 51
- References
- 11
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.